Anne Li March 25th, 2017
Listen below to find out the opinions of Robert A. Figlin, kidney cancer specialist at Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Eric Jonasch, MD at University of Texas MD Anderson Cancer Center, Toni K. Choueiri, MD at Dana-Farber Cancer Institute, Michael R. Harrison, MD at Duke Cancer Institute, and David I. Quinn, MBBS and PhD from USC Norris Cancer Hospital on the future of therapy goals for advanced kidney cancer.
See original article at: https://www.onclive.com/peer-exchange/advanced-kidney-cancer/goals-of-therapy-for-advanced-kidney-cancer
